Johnson & Johnson (NYSE:JNJ) dropped around 2% in last session as Janssen Pharma declared that it will invest in a novel scientific approach, called disease interception, to find ways to intercept type 1 diabetes using new diagnostic and pre-disease intervention strategies. This new approach to T1D is the initial in …
Read More »
Cousins Properties Inc (NYSE:CUZ) (In Eye of Expert, Trend Analysis after Current Fluctuation? Get Her Free Report) reported that it has appointed by Genuine Parts Company to develop a 150,000 square foot corporate headquarters building in Atlanta, Georgia. Construction is slated to begin during the first quarter of 2015 with …
Read More »
Johnson & Johnson (NYSE:JNJ) (In Eye of Expert, Trend Analysis after Current Fluctuation? Get Her Free Report) released on third quarter earnings of $1.50 per share. The company released that its International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%. Johnson & Johnson (NYSE:JNJ) …
Read More »
The Cinema Post Show Bigger Image of Facts